Buy Selank 30 mg in Australia
Selank 30 mg is sold to laboratories and researchers throughout Australia by Australian Research Peptides — $149.99, out of stock for now. Selank is a heptapeptide, seven amino acids in one chain: tuftsin, a four-residue fragment of the antibody immunoglobulin G, extended with a Pro-Gly-Pro tail that slows its breakdown. It is studied in neurotransmission research centred on the GABA system, and arrives freeze-dried and tamper-sealed. Independent lab testing, including a mass-spectrometry identity check, comes before listing. For in vitro research purposes only.
Neuropeptide Research · Lyophilised Powder · Independently lab-tested · SKU 71132
$149.99
Presentation
30 mg per vial
Grade
Research Grade
Form
Lyophilised Powder
Category
Neuropeptide Research
Currently out of stock — stocked lines dispatch same business day before 12pm Sydney time, Mon–Fri
Tracked shipping Australia-wide ·typically 1–2 business days to most areas by Express Post · free post over $199, free Express over $299
For in vitro research purposes only. Not for human consumption. Not for animal consumption. This product is not a drug, food, cosmetic, or dietary supplement. ARP gives no usage, medical or therapeutic guidance of its own.
Selank · 30 mg
$149.99
What we do have in stock
Selank is out of stock and we have not put a substitute in its place. These ship from our shelf in Australia today.
Browse all Neuropeptide Research
About Selank
Most Selank research is animal and cell work on nerve-cell signalling, and gene-expression panels are the usual readout. Studies have looked at genes handling GABA transmission in rat frontal cortex, at inflammation-related genes in mouse spleen, and at BDNF expression in rat hippocampus. All of it is preclinical laboratory work in cells and animals rather than anything established in a person.
Selank is a heptapeptide, meaning one chain of seven amino acids: Thr-Lys-Pro-Arg-Pro-Gly-Pro. The first four are tuftsin, a short natural peptide cut from the heavy chain of human immunoglobulin G. The last three, Pro-Gly-Pro, were added in the laboratory to slow the molecule's breakdown and lengthen how long it lasts. That makes Selank an analogue of tuftsin, not tuftsin itself, and nothing established about one carries automatically to the other.
Australian Research Peptides stocks Selank in one vial size, 30 mg. It is a freeze-dried solid, white through to off-white, sealed in glass under a tamper-evident closure. Whether that solid is the free peptide or its diacetate salt has not been confirmed by the supplier, which is why the specification table carries no molecular mass. Material is sold for in vitro research purposes only.
BAC water (bacteriostatic water) is also in our range.
The peptide calculator works out the mg/mL concentration of a reconstituted vial.
Content reviewed
Further reading: Where Is the Best Place to Buy Peptides in Australia? · Semax vs Selank: What Is the Difference?
Selank specifications, storage and shipping
- Compound: Selank
- Also known as: Selank (Thr-Lys-Pro-Arg-Pro-Gly-Pro; TP-7)
- Class: Synthetic heptapeptide; tuftsin analogue
- Appearance: White to off-white lyophilised powder
- Sizes & SKUs: 30 mg (71132)
- Presentation: sealed glass vial
- Form: Lyophilised Powder
- Grade: Research grade
- Testing: Independently lab-tested before release
- Identity confirmation: Mass spectrometry
- Classification: In vitro research purposes only — laboratory reference material
- Lyophilised — long term
- −20 °C to −80 °C — long-term storage
- Lyophilised — short term
- 2–8 °C — refrigerated, for a few months
- Reconstituted
- 2–8 °C — use within 8–12 weeks
Selank is independently lab-tested before release. No laboratory report is published for this line yet. The COA library lists every product and strength, and says which reports are available.
This line is currently out of stock. Stocked lines ordered before 12pm Sydney time on a business day are dispatched the same day with tracked shipping. Standard delivery within Australia typically takes 2–5 business days. See Shipping & Delivery for details, and follow your parcel on the Track Order page.
For in vitro research purposes only. Not for human consumption. Not for animal consumption. Not a drug, food, cosmetic, or dietary supplement. No therapeutic or medical claims are made.
Questions about Selank
This question guide from Australian Research Peptides covers Selank in Australia: what the listing contains, live buying and delivery questions, research context, handling, testing and comparisons. Start with the quick answers, then open the topic group that matches your search.
Buying, price and availability
Australian Research Peptides sells Selank in Australia, listing it under Neuropeptide Research as one 30 mg freeze-dried vial. ARP dispatches Monday to Friday — Selank itself cannot be sent today, and the 12pm Sydney time rule resumes with the next batch. Express Post runs right across the country, so territory addresses are covered alongside the capitals, and both postal services are tracked. Selank is independently lab-tested, and ARP's CoA library sets out, strength by strength, which certificates have been published so far.
Selank keeps twelve weeks at the outside once dissolved, held cold at 2–8 °C, which is the condition Australian Research Peptides applies to every reconstituted vial rather than anything measured on Selank. Its chain, TKPRPGP, contains none of the five residues handling guides single out as unstable in water — but a favourable sequence does not extend a published window.
Selank ships as a 30 mg vial, three times a standard peptide listing, so for any given concentration it takes three times the liquid of a 10 mg vial. Work the volume out on Australian Research Peptides' calculator rather than assuming a small one; nothing else travels inside the peptide vial.
Selank is sold by Australian Research Peptides strictly as a laboratory research chemical, never as a medicine. ARP does not offer it as a supplement or a veterinary product either, and claims no approval for any such use. The Therapeutic Goods Administration decides what may be supplied as a medicine in Australia. Anyone who needs a ruling on their own situation should ask the TGA or a lawyer.
Selank is named by no prohibited category. The residual heading S0 covers compounds that no state health regulator has approved, and Russia registered Selank for clinical use in 2009, which arguably takes it outside that heading — though no ruling has tested the argument. Competitors under the Australian code should check with Sport Integrity Australia rather than rely on it.
Identity, names and exact format
Selank is a synthetic peptide of seven amino acids, built by adding a three-residue tail to the whole of tuftsin, a short human immune peptide, so that the molecule lasts longer than tuftsin does on its own. It was developed at the Institute of Molecular Genetics in Moscow and is studied in neurotransmission research.
Australian Research Peptides supplies Selank as one freeze-dried peptide in a sealed vial, and nothing else is in the glass. No carrier, no filler, no second ingredient, no liquid. The solid is white to off-white, freeze-dried, and sealed under a tamper-evident closure at the milligram amount printed on the label. The chain inside is Thr-Lys-Pro-Arg-Pro-Gly-Pro. One property of that solid remains open: whether it is the free peptide or the diacetate salt has not been established by the supplier.
A Selank vial takes whatever volume the work needs, and that choice sets the strength. Divide the milligrams in the glass by the millilitres of liquid. Two millilitres into the 30 mg vial leaves 15 mg in each millilitre. Six millilitres into the same vial leaves 5 mg per millilitre. Australian Research Peptides' reconstitution guide has a calculator for any other volume.
Research context and evidence
Selank is studied against the GABA system, and gene expression is what the published work measures. Volkova 2016 read an 84-gene panel in the frontal cortex of male Wistar rats and reported shifts among the genes running GABA transmission. Filatova 2017 found that in cultured IMR-32 nerve cells Selank changed nothing alone, yet altered the response GABA produced by itself. Both studies measured gene activity, not behaviour.
Selank research runs across cells grown in dishes, rodents and a Russian clinical literature. Kolomin 2014 reported that Selank shifted spleen genes tied to inflammation in mice. Inozemtseva 2008 reported a change in how much BDNF — a protein that helps nerve cells survive and grow — the rat hippocampus produced. Volkova 2016 read gene activity across an 84-gene panel in rat frontal cortex. The Russian work has not been replicated in regulator-reviewed Western trials, so the record is real published laboratory work with limited independent confirmation.
Selank is a short chain and is cleaved readily by peptidases, and no half-life value has been published for it. Zolotarev's 2006 tritium-labelling work in Bioorganicheskaia Khimiia identified the pentapeptide TKPRP, the tripeptide TKP and the dipeptides RP and GP as its principal breakdown products. Naming what a molecule turns into is a different task from timing how long it lasts, and for this heptapeptide only the first has been done.
Selank is a heptapeptide, so it has seven amino acids in a single chain. Written out, that chain is Thr-Lys-Pro-Arg-Pro-Gly-Pro. It divides four and three. Thr-Lys-Pro-Arg is the whole of tuftsin, and Pro-Gly-Pro is the tail added in the laboratory. That split is why Selank is classed as a tuftsin analogue, meaning a molecule built on the structure of another.
Selank's published record has two parts: a clinical literature from Russia, where it has been a registered product for years, and preclinical work in rats and cultured nerve cells centred on GABA signalling and gene expression. That evidence has not been replicated in large regulator-reviewed Western trials, so it is real published work with limited independent confirmation.
The 30 mg Selank vial holds three times a standard peptide listing here, so extended bench work runs off a single lot rather than across two. Selank is listed in that one size, so every order draws on the same specification, and the reconstitution arithmetic on this page works from the larger figure throughout.
If a Selank restock sells through before you order, registering again re-arms the alert for the next one; the first notification does not carry over. Small returning batches can move within a day, so an alert that arrives while you are asleep may already be behind the stock by morning.
Selank was developed in Russia, registered there as a medicine, and studied almost entirely by the institutions that developed it — which is why a literature search returns Russian-language journals and few Western trials. That is a fact about where the work was done rather than about its quality, but it does mean much of the evidence is hard to read in English and has not been independently replicated abroad.
Selank is supplied as thirty milligrams of freeze-dried heptapeptide, a larger quantity than most single peptides carry, so a completely bare-looking vial would be unusual. Expect a modest white cake or an even layer across the base. Even at this weight the solid takes up a fraction of the container's volume, since a vial is sized for the liquid it will later hold.
Selank's thirty milligrams of solid takes a little time to vanish completely, and the liquid can look unsettled while that happens. Bubbles from handling look identical to turbidity and clear by themselves. Judge the result only once the vial has reached room temperature and stood undisturbed for around ten minutes — at that point the preparation should be transparent, with no residue on the base.
Handling, storage and measurements
Store sealed Selank powder in a freezer, below minus 15 degrees Celsius, and keep it dry. Selank's own sequence works in its favour. It contains none of the five amino acids Bachem names as shelf-life limiting, so Thr-Lys-Pro-Arg-Pro-Gly-Pro has no fragile link. Protect it from light, and let the vial warm to room temperature before opening, because peptides draw in water. Solutions keep far less well. Bachem advises freezing solutions in small single-use portions and not storing any peptide in solution long term.
Freeze-dried Selank needs a diluent before laboratory work, usually an aqueous one chosen by the laboratory for its method, because the vial arrives dry. The Selank vial itself holds nothing but the peptide, and the volume of diluent added sets the concentration of the finished solution.
Selank is supplied in Australia by Australian Research Peptides — ARP — posting domestically, so no parcel meets a customs officer. The listing runs to a single 30 mg vial in the Neuropeptide Research range, and searches for TP-7 or a mistyped name land on it. The peptide is independently lab-tested, and the CoA library says which listings a certificate has been published against. Selank is unavailable today, and the weekday cut-off applies again once a batch lands, Express or tracked standard, to any state or territory. PayID or bank transfer.
Selank is sold in one 30 mg vial, and Australian Research Peptides sets a single Australian-dollar figure for it. That figure is quoted from the live catalogue rather than fixed in text. A second vial is charged at the same figure as the first. Delivery is quoted on top.
Two Selank vials meet both bars in one step: free Standard tracked post, and the higher Express Post waiver as well. That is unusual across Australian Research Peptides' range, and follows from Selank being a large single-size vial. One vial on its own reaches neither. Adding a Semax vial to a Selank order also takes it over the standard mark without a second Selank vial.
Selank is ordered online from Australian Research Peptides, which lists it in a single 30 mg vial and ships everything it sells from inside Australia. The two payment methods are PayID and bank transfer, and neither asks the buyer for banking details on this site. Instructions for paying follow once an order is placed, and the vial is held against it until the money is matched.
Selank is posted within Australia only, on a domestic timetable of 1–2 business days by Express Post in the better-connected states, up to four elsewhere, with standard tracked post running 2–5. Australian Research Peptides does not ship to any other country, so every Selank order is a domestic parcel and no customs process applies.
Reminder emails go out across the payment window on a Selank order — starting shortly after it is placed, then at intervals, and a last call with hours still left to act. They exist so an unpaid order lapses only when someone has genuinely decided not to pay, never because they forgot. Payment is by PayID or bank transfer.
Testing and batch documents
Selank comes from Australian Research Peptides, not from Chemist Warehouse, which cannot dispense it. Like Semax it is registered in Russia and nowhere else, so there is no local registration to supply against. ARP supplies it as a 30 mg research vial under Neuropeptide Research.
Ordering, payment and Australian delivery
Selank holds no American approval and has never been examined by the Food and Drug Administration. Russia registered it for clinical use in 2009, which makes it licensed there and unapproved everywhere else. That distinction matters, because sellers frequently describe it as simply approved. Freeze-dried research powder is not the registered Russian article regardless.
Selank cannot be prescribed in Australia, because prescribing requires a medicine registered with the TGA and Selank has never been registered here. Its Russian registration carries no weight in an Australian pharmacy. Australian Research Peptides supplies it as laboratory research material, a category that no prescription covers and no pharmacist dispenses.
Selank is registered as a medicine in Russia and nowhere else, which puts an importer in the position of bringing in a foreign-approved product that Australia has never assessed. The TGA sets what may enter as an unapproved good and Border Force decides on arrival. An order from Australian Research Peptides is a domestic parcel, so nothing crosses a border and nothing waits on clearance — the reason domestic supply reaches a bench faster than an import. What that changes is the route the vial takes, not what is in it or what its holder is responsible for.
Selank is independently lab-tested lot by lot before Australian Research Peptides sells any of it. Mass spectrometry weighs the material against the mass expected for a seven-residue chain. That check is what tells Selank apart from plain tuftsin, which is three residues shorter. No matching certificate is currently published for this product and strength.
Access and regulatory questions
Selank is also known as TP-7 and Selank diacetate, the salt PubChem lists on the same record under CAS 129954-34-3. Its sequence name is Thr-Lys-Pro-Arg-Pro-Gly-Pro. Chemists describe Selank as a tuftsin analogue, but tuftsin itself is a different, shorter peptide rather than another name for Selank.
No. Australian Research Peptides lists Selank in one presentation, 30 mg of lyophilised (freeze-dried) powder under a tamper-evident seal, and sells no liquid or ready-made preparation of it. The name is also typed selanc, selanke and salank, and papers file it as TP-7; all of those mean the same seven-residue peptide.
Selank and Semax are different molecules that happen to end the same way. Both are seven amino acids long and both finish with Pro-Gly-Pro. Their opening four residues are unrelated. Selank starts with tuftsin, a piece of an antibody. Semax starts with a fragment of adrenocorticotropic hormone. A different starting sequence means a different compound.
Neither is better documented than the other; they document different molecules. Both are seven-residue Russian-developed peptides ending in Pro-Gly-Pro, and both carry a substantial literature. Selank opens on tuftsin, a fragment of the antibody immunoglobulin G, and its published work sits in neurotransmission research. Semax opens on an ACTH(4-7) fragment — a four-residue piece of a hormone the body makes — and its work looks at nerve growth factors and monoamine signalling.
No published study has run Selank and Semax in combination; they are distinct molecules from the same Russian research programme, with separate literatures, rather than two versions of one compound. Selank is built on tuftsin and Semax on an ACTH fragment.